BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24184336)

  • 1. Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201.
    Switzer GE; Bruce JG; Harrington D; Haagenson M; Drexler R; Foley A; Confer D; Bishop M; Anderlini P; Rowley S; Leitman SF; Anasetti C; Wingard JR
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):118-27. PubMed ID: 24184336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.
    Burns LJ; Logan BR; Chitphakdithai P; Miller JP; Drexler R; Spellman S; Switzer GE; Wingard JR; Anasetti C; Confer DL;
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1108-1116. PubMed ID: 27013014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
    Pulsipher MA; Chitphakdithai P; Logan BR; Shaw BE; Wingard JR; Lazarus HM; Waller EK; Seftel M; Stroncek DF; Lopez AM; Maharaj D; Hematti P; O'Donnell PV; Loren AW; Leitman SF; Anderlini P; Goldstein SC; Levine JE; Navarro WH; Miller JP; Confer DL
    Blood; 2013 Jan; 121(1):197-206. PubMed ID: 23109243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials.
    Farhadfar N; Ahn KW; Bo-Subait S; Logan B; Stefanski HE; Hsu JW; Panch S; Confer D; Liu H; Badawy SM; Beitinjaneh A; Diaz MA; Hildebrandt GC; Kelkar AH; Lazarus HM; Murthy HS; Preussler JM; Schears RM; Sharma A; van der Poel M; Bruce JG; Pulsipher MA; Shaw BE; Wingard JR; Switzer GE
    Transplant Cell Ther; 2022 Sep; 28(9):603.e1-603.e7. PubMed ID: 35688325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predonation health-related quality of life scores predict time to recovery in hematopoietic stem cell donors.
    Billen A; Madrigal JA; Strydom A; Szydlo RM; Switzer GE; Shaw BE
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):350-6. PubMed ID: 25452034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.
    Pulsipher MA; Logan BR; Kiefer DM; Chitphakdithai P; Riches ML; Rizzo JD; Anderlini P; Leitman OF; Kobusingye H; Besser RM; Miller JP; Drexler RJ; Abdel-Mageed A; Ahmed IA; Akard LP; Artz AS; Ball ED; Bayer RL; Bigelow C; Bolwell BJ; Broun ER; Delgado DC; Duckworth K; Dvorak CC; Hahn TE; Haight AE; Hari PN; Hayes-Lattin BM; Jacobsohn DA; Jakubowski AA; Kasow KA; Lazarus HM; Liesveld JL; Linenberger M; Litzow MR; Longo W; Magalhaes-Silverman M; McCarty JM; McGuirk JP; Mori S; Parameswaran V; Prasad VK; Rowley SD; Rybka WB; Sahdev I; Schriber JR; Selby GB; Shaughnessy PJ; Shenoy S; Spitzer T; Tse WT; Uberti JP; Vusirikala M; Waller EK; Weisdorf DJ; Yanik GA; Navarro WH; Horowitz MM; Switzer GE; Confer DL; Shaw BE
    Haematologica; 2019 Apr; 104(4):844-854. PubMed ID: 30381298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.
    Shaw BE; Logan BR; Kiefer DM; Chitphakdithai P; Pedersen TL; Abdel-Azim H; Abidi MH; Akpek G; Diaz MA; Artz AS; Dandoy C; Gajewski JL; Hematti P; Kamble RT; Kasow KA; Lazarus HM; Liesveld JL; Majhail NS; O'Donnell PV; Olsson RF; Savani BN; Schears RM; Stroncek DF; Switzer GE; Williams EP; Wingard JR; Wirk BM; Confer DL; Pulsipher MA
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1830-8. PubMed ID: 26116089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in peripheral blood stem cell donors and bone marrow donors: a prospective study in Japan.
    Fujimoto A; Suzuki R; Orihara K; Iida M; Yamashita T; Nagafuji K; Kanamori H; Kodera Y; Miyamura K; Okamoto S; Hino M
    Int J Hematol; 2020 Jun; 111(6):840-850. PubMed ID: 32172446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study.
    Switzer GE; Bruce JG; Kiefer DM; Kobusingye H; Abebe KZ; Drexler R; Besser RM; Confer DL; Horowitz MM; King RJ; Shaw BE; Riches M; Hayes-Lattin B; Linenberger M; Bolwell B; Rowley SD; Litzow MR; Pulsipher MA
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2365-2371. PubMed ID: 32829080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.
    Pulsipher MA; Chitphakdithai P; Logan BR; Navarro WH; Levine JE; Miller JP; Shaw BE; O'Donnell PV; Majhail NS; Confer DL
    Blood; 2014 Jun; 123(23):3655-63. PubMed ID: 24735965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program.
    Miller JP; Perry EH; Price TH; Bolan CD; Karanes C; Boyd TM; Chitphakdithai P; King RJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):29-36. PubMed ID: 18721778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting.
    Bredeson C; Leger C; Couban S; Simpson D; Huebsch L; Walker I; Shore T; Howson-Jan K; Panzarella T; Messner H; Barnett M; Lipton J
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):405-14. PubMed ID: 15148494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors.
    Yanagisawa R; Hirakawa T; Doki N; Ikegame K; Matsuoka KI; Fukuda T; Nakamae H; Ota S; Hiramoto N; Ishikawa J; Ara T; Tanaka M; Koga Y; Kawakita T; Maruyama Y; Kanda Y; Hino M; Atsuta Y; Yabe H; Tsukada N
    Int J Hematol; 2023 Mar; 117(3):421-427. PubMed ID: 36403180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.
    Young JH; Logan BR; Wu J; Wingard JR; Weisdorf DJ; Mudrick C; Knust K; Horowitz MM; Confer DL; Dubberke ER; Pergam SA; Marty FM; Strasfeld LM; Brown JWM; Langston AA; Schuster MG; Kaul DR; Martin SI; Anasetti C;
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):359-370. PubMed ID: 26409243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial consequences of living kidney donation: a prospective multicentre study on health-related quality of life, donor-recipient relationships and regret.
    Wirken L; van Middendorp H; Hooghof CW; Sanders JF; Dam RE; van der Pant KAMI; Wierdsma JM; Wellink H; van Duijnhoven EM; Hoitsma AJ; Hilbrands LB; Evers AWM
    Nephrol Dial Transplant; 2019 Jun; 34(6):1045-1055. PubMed ID: 30544241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors.
    Pahnke S; Larfors G; Axdorph-Nygell U; Fischer-Nielsen A; Haastrup E; Heldal D; Itälä-Remes M; Johansson JE; Kauppila M; Lenhoff S; Ljungman P; Niittyvuopio R; Sandstedt A; Hägglund H
    J Clin Apher; 2018 Jun; 33(3):226-235. PubMed ID: 28833474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34
    Stroncek DF; Shaw BE; Logan BR; Kiefer DM; Savani BN; Anderlini P; Bredeson CN; Hematti P; Ganguly S; Diaz MA; Abdel-Azim H; Ahmed I; Maharaj D; Seftel M; Beitinjaneh A; Seo S; Yared JA; Halter J; O'Donnell PV; Hale GA; DeFilipp Z; Lazarus H; Liesveld JL; Zhou Z; Munshi P; Olsson RF; Kasow KA; Szer J; Switzer GE; Chitphakdithai P; Shah N; Confer DL; Pulsipher MA
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):175-184. PubMed ID: 28958894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between graft product and donor side effects following bone marrow or stem cell donation.
    Favre G; Beksaç M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szer J; Bradstock K; Buzyn A; Matcham J; Gratwohl A; Schmitz N;
    Bone Marrow Transplant; 2003 Nov; 32(9):873-80. PubMed ID: 14561987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the haematopoietic stem cell donation experience: is there room for improvement?
    Billen A; Madrigal JA; Shaw BE
    Bone Marrow Transplant; 2014 Jun; 49(6):729-36. PubMed ID: 24464144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable recovery profiles and good reliability among youngest unrelated stem cell donors supports lowering the minimum donor registration age.
    Ros-Soto J; Pryce A; Zoubek E; Burlton C; Szydlo R; Anthias C
    J Clin Apher; 2023 Oct; 38(5):562-572. PubMed ID: 37309733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.